Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-05-31 00:00:00 ET · period of report 2024-05-29 · accession 0001628280-24-026084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-31 | 2024-05-29 | BLFS | Foster Karen A. | Chief Quality, Ops | S - Sale | $21.78 | -408 | 158.2K | -0.3% | -$8,886 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-29 | S | D | 408 | $21.78 | 158,171 | D | — | — |